STUDY OF RITUXIMAB EFFICACY PREDICTORS IN PATIENTS WITH SYSTEMIC SCLEROSIS WITH INTERSTITIAL LUNG DISEASE

被引：0
|
作者：
Koneva, Olga
Ananyeva, Lidia
Garzanova, Liudmila
Desinova, Oxana
Ovsynnikova, Olga
Starovoytova, Mayya
机构：
来源：
CHEST | 2021年 / 160卷 / 04期
关键词：
D O I：
10.1016/j.chest.2021.07.1897
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：2148A / 2148A
页数：1
相关论文
共 50 条
  • [21] PREDICTORS OF INTERSTITIAL LUNG INVOLVEMENT IN SYSTEMIC SCLEROSIS
    Sieiro Santos, Cristiana
    Rego Salgueiro, Ruben
    Moriano Morales, Clara
    Alvarez Castro, Carolina
    Diez Alvarez, Elvira
    RHEUMATOLOGY, 2023, 62
  • [22] RITUXIMAB FOR THE TREATMENT OF SYSTEMIC SCLEROSIS ASSOCIATED INTERSTITIAL LUNG DISEASE: A CASE SERIES
    Ananyeva, L.
    Desinova, O.
    Starovoytova, M.
    Koneva, O.
    Yutkina, N.
    Onsyannikova, O.
    Volkov, A.
    Aleksandrova, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 648 - 648
  • [23] Incidence and predictors of interstitial lung disease (ILD) in Thai patients with early systemic sclerosis: Inception cohort study
    Wangkaew, Suparaporn
    Euathrongchit, Juntima
    Wattanawittawas, Pittaporn
    Kasitanon, Nuntana
    Louthrenoo, Worawit
    MODERN RHEUMATOLOGY, 2016, 26 (04) : 588 - 593
  • [24] EFFICIENCY OF RITUXIMAB THERAPY IN PATIENTS WITH INTERSTITIAL LUNG DISEASE ASSOCIATED WITH SYSTEMIC SCLEROSIS DEPENDING ON THE FORM AND DURATION OF THE DISEASE
    Garzanova, Liudmila
    Ananyeva, Lidia
    Koneva, Olga A.
    Ovsyannikova, Olga
    Desinova, Oxana
    Starovoytova, Mayya
    Shayakhmetova, Rushana
    Khelkovskaya-Sergeeva, Anna
    CHEST, 2023, 164 (04) : 3118A - 3119A
  • [25] PROTEIN BIOMARKERS AS PREDICTORS OF DISEASE PROGRESSION IN PATIENTS WITH SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE
    Chiang, Giuliana C. Cerro
    Tahmineh, Romero
    David, Elashoff
    Mitra, Mastali
    Van Eyk, Jennifer
    Boin, Francesco
    Chen, Peter
    Zaman, Tanzira
    CHEST, 2022, 162 (04) : 1311A - 1311A
  • [26] RITUXIMAB EXPERIENCE IN PATIENTS WITH LONGSTANDING SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE: A SERIES OF 14 PATIENTS
    Sari, A.
    Guven, D.
    Armagan, B.
    Kilic, L.
    Erden, A.
    Akdogan, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1262 - 1263
  • [27] Rituximab treatment for systemic sclerosis-associated interstitial lung disease: a case series of 13 patients
    Morgan, Kelly
    Woollard, Charlotte
    Beinart, Dylan
    Host, Lauren, V
    Roddy, Janet
    INTERNAL MEDICINE JOURNAL, 2023, 53 (07) : 1147 - 1153
  • [28] PROGRESSIVE INTERSTITIAL LUNG DISEASE IN PATIENTS WITH SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE
    Cuomo, G.
    Di Vico, C.
    Perretta, D.
    Iandoli, C.
    Ciaburri, R.
    Adamo, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1657 - 1658
  • [29] Predictors of Exercise-Induced Oxygen Desaturation in Systemic Sclerosis Patients With Interstitial Lung Disease
    Someya, Fujiko
    Mugii, Naoki
    Hasegawa, Minoru
    Yahata, Tetsutarou
    Nakagawa, Takao
    RESPIRATORY CARE, 2014, 59 (01) : 75 - 80
  • [30] The Efficacy of Rituximab in Systemic Sclerosis Joint Disease: A Pilot Study
    Borrell Panos, Helena
    Narvaez, Javier
    Jose Alegre, Juan
    Castellvi, Ivan
    Albert Espi, Gloria
    Heredia, Sergi
    Toniolo, Elide
    Miquel Nolla, Joan
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
12345